# POSITRON CORP (POSC) — capital_raise/public_offering [announced]
Source: sec.gov · situation sit_4142ef4d8d1ca00c23cc · public 9771895010783403081 · retrieved 2026-08-19T11:33:35.224Z

## Overview
Positron Corporation is a Texas corporation engaged in the development and commercialization of advanced medical imaging systems, including a PET-CT platform.

Positron Corporation entered into a Line of Credit Agreement with George Ortiz on August 13, 2026, providing a maximum aggregate principal amount of $2,000,000. The company may draw funds at its discretion, subject to a maximum draw of $500,000 per calendar quarter and a minimum draw of $50,000, with amounts repaid eligible for reborrowing. The outstanding principal balance bears interest at 12% per annum, payable quarterly in arrears, with an interest-only period for the first twelve months followed by principal payments in the second twelve months. All advances are due and payable on August 13, 2028 (twenty-four months from the effective date), unless extended by mutual written agreement. As additional consideration, Positron issued Mr. Ortiz warrants to purchase 300,000 shares of common stock at an exercise price of $1.50 per share, expiring December 31, 2030. Upon a default in payment of interest or principal, the warrant exercise price automatically reprices to $1.00 per share.

## Terms
- Counterparty: George Ortiz · Deal value: $2.0M · Consideration: cash · Price/share: $1.5

## Key dates
- Announced 2026-08-18 · Expiry 2030-12-31

## Timeline
- 2026-08-18 · 8-K (0001539497-26-002298): 8-K - POSITRON CORP — *Positron Corporation is a Texas corporation engaged in the development and commercialization of advanced medical imaging systems, including a PET-CT platform.* Positron Corporation entered into a Line of Credit Agreement with George Ortiz on August 13, 2026, providing a maximum aggregate principal amount of $2,000,000. The company may draw funds at its discretion, subject to a maximum draw of $500,000 per calendar quarter and a minimum draw of $50,000, with amounts repaid eligible for reborrowing. The outstanding principal balance bears interest at 12% per annum, payable quarterly in arrears, with an interest-only period for the first twelve months followed by principal payments in the second twelve months. All advances are due and payable on August 13, 2028 (twenty-four months from the effective date), unless extended by mutual written agreement. As additional consideration, Positron issued Mr. Ortiz warrants to purchase 300,000 shares of common stock at an exercise price of $1.50 per share, expiring December 31, 2030. Upon a default in payment of interest or principal, the warrant exercise price automatically reprices to $1.00 per share.
  https://www.sec.gov/Archives/edgar/data/844985/0001539497-26-002298.txt

## Citations
- 0001539497-26-002298 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000153949726002298